NCT06391177View on ClinicalTrials.gov

A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

September 13, 2024

Study Completion Date

September 19, 2024

Conditions
Erosive EsophagitisHeartburnSymptomatic Nonerosive Gasroesophageal Reflux DiseaseHelicobacter Pylori Infection
Interventions
DRUG

Vonoprazan

Oral tablet.

Trial Locations (1)

89113

PPD Development, LP, Las Vegas

Sponsors
All Listed Sponsors
lead

Phathom Pharmaceuticals, Inc.

INDUSTRY

NCT06391177 - A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily | Biotech Hunter | Biotech Hunter